| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Revenue - related party | ||||||
1,708 | 3,506 | 1,725 | 2,570 | 590 | ||
Operating expenses: | ||||||
Research and development | ||||||
19,325 | 33,654 | 19,081 | 20,267 | 11,323 | ||
General and administrative | ||||||
7,233 | 6,592 | 5,419 | 4,467 | 2,488 | ||
Total operating expenses | ||||||
26,558 | 40,246 | 24,500 | 24,734 | 13,811 | ||
Loss from operations | ||||||
-24,850 | -36,740 | -22,775 | -22,164 | -13,221 | ||
Other income | ||||||
Interest income | ||||||
136 | 148 | 98 | 47 | 2 | ||
Other income | ||||||
0 | 225 | 0 | - | - | ||
Interest expense and debt amortization | ||||||
- | - | - | 344 | 235 | ||
Change in fair value of warrant liabilities | ||||||
- | - | - | 0 | 438 | ||
Total other income | ||||||
136 | 373 | 98 | -297 | -671 | ||
Net Loss | ||||||
-24,714 | -36,367 | -22,677 | -22,461 | -13,892 | ||
Loss per Share: | ||||||
Basic and diluted net loss per common share outstanding | ||||||
-0.70 | -1.27 | -1.00 | -1.04 | -1.41 | ||
Basic and diluted weighted average number of common shares outstanding | ||||||
35,303 | 28,553 | 22,618 | 21,544 | 9,855 | ||